I am a cardiovascular biologist and I have expertise in studying vascular biology, platelet biology and thrombosis, as well as heart failure. I am exploring the detailed mechanisms regarding how TYMP affects platelet function and how it affects the development of other chronic diseases, including metabolic syndrome, non-alcohol fatty liver disease, and type 2 diabetes, as well as these diseased-condition associated high risk of thrombosis. In addition to modern cell biology and molecular biology techniques, my lab has established several animal models. These include, but are not limited to, intravital microscopy-based FeCl3-induced thrombosis models, guidewire-induced carotid artery injury model, abdominal aortic aneurysm model, and ischemia/reperfusion models. My long-term goal is to develop novel therapeutics for the life-threatening atherosclerotic and thrombotic cardiovascular diseases.
I am a cardiovascular biologist and I have expertise in studying vascular biology, platelet biology and thrombosis, as well as heart failure. I am exploring the detailed mechanisms regarding how TYMP affects platelet function and how it affects the development of other chronic diseases, including metabolic syndrome, non-alcohol fatty liver disease, and type 2 diabetes, as well as these diseased-condition associated high risk of thrombosis. In addition to modern cell biology and molecular biology techniques, my lab has established several animal models. These include, but are not limited to, intravital microscopy-based FeCl3-induced thrombosis models, guidewire-induced carotid artery injury model, abdominal aortic aneurysm model, and ischemia/reperfusion models. My long-term goal is to develop novel therapeutics for the life-threatening atherosclerotic and thrombotic cardiovascular diseases.